What's Dave Lashmet pitching for Alzheimer's riches?
| |
| DAILY UPDATE
June 14, 2017 |
| |
| | Greetings! |
Dave Lashmet is selling Stansberry's Investment Advisory by using a story about expected hot results from an Alzheimer's Disease drug next month, at meetings he'll be attending in mid-June. Alzheimer's treatments get everyone excited, both for humanitarian and "giant piles of cash" reasons, so what's his pitch about this time? Just click below to... |
| |
|
| Disclaimer: Nothing in this email or in the linked articles should be considered to be individual investment advice -- we can't tell you what you should do with your money, we can just share our opinions and perspective. Our authors try to use reliable information sources but also make mistakes of both fact and judgement on occasion, so all assertions should be checked and confirmed. You should speak with your financial advisor and understand everything fully before committing money to any investment.
Most issues of this email newsletter include advertising, and it should not be assumed that the presence of an advertisement means that the product or service advertised is endorsed by Stock Gumshoe or the author. For full disclaimers, disclosure information, and privacy policies please see the prominent links at the bottom of each page at StockGumshoe.com.
If you wish to unsubscribe to these mailings, there are links at both the bottom and top of this email that you can use to do so permanently and safely, we have no wish to email people who don't want to receive these messages. Please note that unsubscribing using the link below applies only to receiving emails, if you are a member of the Stock Gumshoe Irregulars that membership will not automatically change or be canceled. Please contact us if you need to change a paid membership.
|
| |
|
